PepGen Inc. (PEPG) research
PepGen Inc.- Sector
- Biotechnology
- Last price
- $2.90
- As of
PepGen Inc. (PEPG): 6 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 10-Q filed 2026-08-06.
As of . Source: SEC EDGAR filings for PEPG. Method and limitations.
Share the PEPG intelligence card
See PEPG live in the terminal
Track PEPG's insider trades, 13F flows, options positioning, and cross asset confluence as they update, on one live board. Free account.
Open the live PEPG terminal, freeActive signals for PEPG
- highINSTITUTIONAL_SURGE
RENAISSANCE TECHNOLOGIES LLC added +2576% to PEPG (2026Q2)
- highINSTITUTIONAL_EXIT
CITADEL ADVISORS LLC cut 78% of PEPG (2026Q2)
- highINSTITUTIONAL_SURGE
CITADEL ADVISORS LLC added +1000% to PEPG (2026Q2)
- highINSTITUTIONAL_EXIT
TWO SIGMA INVESTMENTS, LP cut 64% of PEPG (2026Q2)
- highINSTITUTIONAL_SURGE
RENAISSANCE TECHNOLOGIES LLC added +2576% to PEPG (2026Q2)
FREE, NO ACCOUNT
Every signal on PEPG, as it fires
You are seeing 5 of 22 signals recorded on PEPG since 2026-06-05.
The five above all landed on 2026-09-06. The other 17 were recorded on 4 other days. 17 of the 22 are institutional flow rows, which arrive in batches on filing days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in PEPG (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| VIKING GLOBAL INVESTORS LPCUSIP 713317105 · 2026Q2 | $6.3M | 0.02% | , |
| MILLENNIUM MANAGEMENT LLCCUSIP 713317105 · 2026Q2 | $3.2M | 0.00% | , |
| RENAISSANCE TECHNOLOGIES LLCCUSIP 713317105 · 2026Q2 | $2.7M | 0.00% | , |
| CITADEL ADVISORS LLCCUSIP 713317105 · 2026Q2 | $1.2M | 0.00% | , |
| TWO SIGMA INVESTMENTS, LPCUSIP 713317105 · 2026Q2 | $119K | 0.00% | , |
| Point72 Asset Management, L.P.CUSIP 713317105 · 2026Q2 | $71K | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, PEPG
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
PEPG against its peers
PEPG's return on equity of -60.8% ranks in the 34th percentile of 21 Biotechnology sub-industry peers, fiscal periods ending between 2025-09-30 and 2025-12-31.
| Metric | PEPG | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | n/a | 21.0M | n/a | 15 |
| Operating margin | n/a | -279.5% | n/a | 15 |
| Net margin | n/a | -98.2% | n/a | 15 |
| Return on equity | -60.8% | -33.3% | 34 | 21 |
Peers (24): NKTX, CHRS, XGN, IPHA, ELDN, TARA, SRZN, ALEC, ADAG, ORMP, AVXL, ACOG, MSLE, CNTN, SLGL, NGEN, KROS, PLX, IVVD, VYGR, YDES, ABOS, ANTX, CGEN. Left out: VRXA (no annual filing). Fiscal periods ending between 2025-09-30 and 2025-12-31. Every figure is one full fiscal year read from one annual filing (PEPG: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
See more PEPG signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to PEPGand get the insider, 13F, options, and confluence read in one view.